Akèy › Leksemi biphenotipik egi › West Virginia
Etid klinik pou Leksemi biphenotipik egi nan West Virginia
3 etid pou Leksemi biphenotipik egi ap chèche patisipan nan sit nan West Virginia.
Tèks ofisyèl etid la (Anglè)
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
- West Virginia University Charleston Division, Charleston
Ap rekriteFaz 3
365 Days – 25 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT03959085The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- West Virginia University Healthcare, Morgantown
Ap rekriteFaz 1/2
Jiska laj 22 · Tout sèks · Mizajou Aug 25, 2026 · NCT04726241Subcutaneous Blinatumomab for Treatment of Adult Patients With CD19-Positive Mixed Phenotype Acute Leukemia (MPAL)
- West Virginia University Cancer Institute, Morgantown
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Apr 13, 2026 · NCT07222579Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.